Corrine Savill

Insider Reports History

Entity
Individual
Location
C/O Cullinan Oncology, Llc, One Main Street Suite 520, Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Corrine Savill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. Chief Business Officer Common Stock 203K $3.29M $16.18 Feb 22, 2024 Direct
Cullinan Oncology, Inc. Chief Business Officer Stock Option (Right to Buy) 75K Feb 22, 2024 Direct

Insider Reports Filed by Corrine Savill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Feb 22, 2024 2 $0 4 Feb 23, 2024 Chief Business Officer
CGEM Cullinan Oncology, Inc. Feb 1, 2024 3 -$475K 4 Feb 2, 2024 Chief Business Officer
CGEM Cullinan Oncology, Inc. Jan 29, 2024 4 -$392K 4 Jan 30, 2024 Chief Business Officer
CGEM Cullinan Oncology, Inc. Jan 22, 2024 7 -$338K 4 Jan 24, 2024 Chief Business Officer
CGEM Cullinan Oncology, Inc. Feb 17, 2023 2 $0 4 Feb 21, 2023 Chief Business Officer
CGEM Cullinan Oncology, Inc. Jul 18, 2022 2 -$304K 4 Jul 21, 2022 Acting Chief Business Officer
CGEM Cullinan Oncology, Inc. Jul 11, 2022 2 -$533K 4 Jul 12, 2022 Acting Chief Business Officer
CGEM Cullinan Oncology, Inc. Feb 11, 2022 2 $0 4 Feb 15, 2022 Acting Chief Business Officer